MENU
Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Oct 25, 2023

Trader Robot Strikes Again with +5.44% Weekly Gain on $ACET

In the world of AI trading robots, the "Trend Trader, Popular Stocks: Price Action Trading Strategy (TA&FA)" has become a popular choice for investors. These sophisticated bots have been making waves in the financial market, recently delivering impressive results. During the previous week, these trading bots managed to secure a remarkable gain of +5.44% while actively trading ACET. In this article, we will delve into the specifics of ACET's earnings and market trends, shedding light on what's driving the success of these AI trading robots.

MACD Indicator: A Positive Omen for ACET

One of the key factors contributing to the success of the AI trading bots is the analysis of the Moving Average Convergence Divergence (MACD) indicator for ACET. On October 5, 2023, the MACD Histogram for ACET crossed above the signal line, signaling a positive trend. This is a significant technical indicator that often piques the interest of traders.

Historical data shows that when ACET's MACD turns positive, the stock tends to continue its upward trajectory. Out of 39 instances where the MACD turned positive, ACET's stock price rose in 34 of them over the following month. This historical data indicates an impressive 87% success rate for predicting an upward trend in ACET's stock price.

Earnings Report: A Mixed Bag for ACET

One critical aspect that AI trading bots consider when making trading decisions is the company's earnings. ACET reported its last earnings on August 09, which showed earnings per share (EPS) of -75 cents. This result fell short of the estimated -46 cents, highlighting a significant earnings miss.

To put this in perspective, with 153.57K shares outstanding, the current market capitalization for ACET stands at 64.60M. This earnings report will undoubtedly have an impact on the trading strategies employed by AI bots.

Dividend Dates and Their Implications

Investors often consider dividends when making trading decisions. ACET paid a quarterly dividend of $0.01 per share, with a record date of October 09, 2018, and an ex-dividend date of September 21, 2018. The ex-dividend date is an important factor to consider. If you buy a stock on or after this date, you won't receive the next dividend payment. Instead, the dividends are retained by the seller. However, if you purchase the stock before the ex-dividend date, you will receive the dividends.

Market Capitalization Insights

Understanding a company's market capitalization is crucial for investors. In the biotechnology industry, ACET's market capitalization of 64.60M places it on the lower end of the spectrum. The average market capitalization for companies in this industry is 2.19B, with a wide range of values, from 402M to 429.71B. For comparison, the highest-valued company in this group is NVO at 429.71B, while the lowest is PNEXF at 402M.

Price Trends and Volatility in the Biotechnology Industry

Market trends play a significant role in the success of AI trading bots. In the biotechnology industry, the average weekly price growth for all stocks was -3%, indicating a slight decline. The average monthly price growth was -5%, while the average quarterly price growth was -15%. These figures suggest a challenging environment for traders in this industry.

Notably, ADXN experienced the highest price growth at a staggering 1,510%, showcasing the potential for significant gains in the biotech sector. Conversely, ATHX experienced a substantial decline, with a -82% drop in its stock price, highlighting the industry's inherent volatility.

Volume: An Indicator of Trading Activity

Trading volume is a crucial indicator for traders and AI trading bots. In the biotechnology industry, the average weekly volume growth for all stocks was -25%, suggesting a decline in trading activity. On a monthly basis, the average volume growth was -6%, indicating a persistent downtrend. However, the quarterly volume growth was a notable exception, showing a significant 72% increase in trading activity.

In summary, the success of AI trading robots is often attributed to their ability to analyze a plethora of data, including technical indicators, earnings reports, market trends, and trading volumes. The positive MACD crossover for ACET, despite a recent earnings miss, suggests a potential upward trend. However, the broader trends in the biotechnology industry and trading volumes indicate a more challenging environment.

Related Ticker: ACET

ACET in +19.63% Uptrend, advancing for three consecutive days on March 24, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ACET advanced for three days, in of 268 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ACET just turned positive on March 24, 2025. Looking at past instances where ACET's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where ACET's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ACET as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ACET moved below its 50-day moving average on March 27, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ACET crossed bearishly below the 50-day moving average on March 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACET declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ACET broke above its upper Bollinger Band on March 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ACET entered a downward trend on March 31, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.335) is normal, around the industry mean (13.677). P/E Ratio (0.000) is within average values for comparable stocks, (64.969). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.870). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (255.565).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ACET’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACET’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Sarepta Therapeutics (NASDAQ:SRPT), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.22B. The market cap for tickers in the group ranges from 151 to 302.51B. NONOF holds the highest valuation in this group at 302.51B. The lowest valued company is MYMX at 151.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -9%. For the same Industry, the average monthly price growth was -13%, and the average quarterly price growth was -12%. MMIRF experienced the highest price growth at 470%, while MYNDF experienced the biggest fall at -84%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 43%. For the same stocks of the Industry, the average monthly volume growth was 6% and the average quarterly volume growth was 119%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 84
Price Growth Rating: 70
SMR Rating: 94
Profit Risk Rating: 95
Seasonality Score: -2 (-100 ... +100)
View a ticker or compare two or three
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a distributor of pharmaceutical intermediate ingrediants and other industrial chemicals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Distributors
Address
131 Dartmouth Street
Phone
+1 650 503-9095
Employees
143
Web
https://www.adicetbio.com
Ad is loading...
"🚀 PHAXIAM Therapeutics SA Skyrockets +18.82%! Dive into this biotech penny stock's stellar week and the industry's broader movements. 📈🔬
Explore annualized returns of +110% for Day Traders and +50% for Swing Traders using Price Action Trading Strategies (TA&FA) on popular managed healthcare stocks like $BIOS $CI $CNC $ELV $HUM $MOH $UNH. Stay updated on the 1-week change of +3% in this dynamic market.
The ethanol industry encompasses a diverse range of business activities, primarily focusing on the production of ethanol and sugar. Beyond these core products, companies within this theme also engage in the development of related assets, such as fuel storage tanks.
Cisco Systems set to soar! 🚀 A.I. predicts +4% growth in the coming month. Is CSCO the next big move in your portfolio? 📈💰
#trading
The Office Equipment/Supplies sector has emerged as a standout performer in recent times, posting an impressive 6.13% increase in its performance over the past week. This surge in performance is supported by a group of tickers, including $ACTG, $SCS, $HNI, $EBF, and $ACCO, which have collectively displayed a positive outlook. In this article, we will delve into the theme of this sector and analyze the group of tickers within it that are driving this positive momentum.
"IBM Skyrockets: +15.54% Quarterly Jump! Dive into the data behind this tech titan's remarkable rally. 📈🚀"
#investment#trading
The pharmaceutical sector is known for its dynamic nature, with companies often experiencing rapid shifts in performance and sentiment. In the past week, pharmaceutical companies, as represented by a group of tickers including RPRX, CALT, INZY, and HRMY, have seen a noteworthy increase in performance, surging by +3.13%. In this article, we will delve into the details of this trend, explore key indicators, and assess the outlook for these companies.
The term 'challenging disorders' envelops a vast expanse of the healthcare sector, extending from medical devices, facilities to biotechs, and pharmaceutical firms.
The ocean transportation sector has been making waves recently, experiencing a significant performance boost of +3.74% over the past week. In this article, we'll delve into the theme and explore the key tickers within this sector, shedding light on their market capitalization, recent price movements, volume trends, and fundamental analysis ratings.
Forest products encompass materials harvested from forestry intended for direct utilization or commercial activities.
The toy industry has seen some significant ups and downs in recent times, with a cluster of notable companies taking center stage in this exciting and ever-evolving market. In this article, we delve into the recent performance of select toy companies, examining key indicators and trends that have shaped their stock movements.
Dive into the dynamics behind the recent 2.68% rise in the Wholesale Distributors sector. With standout performers like $GIC, $POOL, $SITE, $FERG, and $CNM, we dissect the market movements and pivotal factors driving this uptrend. Read on to stay ahead!
🚀 Biocept (BIOC) surges +51.63% in a month! Amid industry downtrends, BIOC shines. What's next for this penny stock? 📈
#latest#investment
The aluminum construction companies have experienced a significant boost, with the segment seeing a +11.13% increase in performance over the past week. This growth is largely driven by the rising demand for lightweight materials, particularly in the automotive sector, where aluminum is being widely adopted to improve fuel efficiency. The aluminum industry plays a vital role in the U.S. economy, generating approximately $71 billion annually in direct economic impact, according to The Aluminum Association.
Unlock the potential of AI-powered swing trading with robots designed to track dips in top S&P 500 stocks. Whether you're a beginner or experienced trader, these tools help manage up to $20k per position, balancing risk and reward with advanced algorithms and market insights. Discover how to maximize returns in volatile markets!
Discover Tickeron's new AI-driven trading bots designed for high-volatility markets and impulse price action. Leveraging Financial Learning Models (FLMs) and technical analysis, these bots optimize trades, offer a 70% win rate, and execute strategies for day traders focused on fast market moves.
The Diesel Companies segment has displayed a notable increase of +9.44% in performance over the past week. This uptick highlights a positive trend in the sector, encompassing companies involved in the manufacturing of diesel vehicles and the distribution of transportation fuels.
The medical companies segment has experienced a notable increase in performance, recording a weekly gain of +3.53%. This sector encompasses companies involved in the production and supply of pharmaceuticals and essential medical products, catering to a broad spectrum of healthcare needs. Their product offerings include surgical apparel, gloves, hospital furniture, fluid management solutions, and specialized equipment for cosmetic and surgical procedures.
Tickeron launches AI-powered Stock Picker robots to assist hedge fund managers with sector rotation, growth-focused small-cap stocks, and strategic risk management. Using proprietary FLMs, Stock Pickers offer quant-driven signals and adaptive strategies for long-term growth and investment
Tickeron unveils an intuitive AI trading bot interface, offering tailored strategies for day, swing, and trend traders. From beginners to pros, discover tools designed to optimize trading precision, adapt to market volatility, and provide hedge fund-level insights for smarter investments.
#latest#popular#trading